Cargando…

Combination Treatment for Visceral Leishmaniasis Patients Coinfected with Human Immunodeficiency Virus in India

Background. There are considerable numbers of patients coinfected with human immunodeficiency virus (HIV) and visceral leishmaniasis (VL) in the VL-endemic areas of Bihar, India. These patients are at higher risk of relapse and death, but there are still no evidence-based guidelines on how to treat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mahajan, Raman, Das, Pradeep, Isaakidis, Petros, Sunyoto, Temmy, Sagili, Karuna D, Lima, Marıa Angeles, Mitra, Gaurab, Kumar, Deepak, Pandey, Krishna, Van geertruyden, Jean-Pierre, Boelaert, Marleen, Burza, Sakib
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2015
Materias:	Articles and Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583582/ https://www.ncbi.nlm.nih.gov/pubmed/26129756 http://dx.doi.org/10.1093/cid/civ530

Ejemplares similares

Visceral Leishmaniasis and HIV Co-infection in Bihar, India: Long-term Effectiveness and Treatment Outcomes with Liposomal Amphotericin B (AmBisome)
por: Burza, Sakib, et al.
Publicado: (2014)

Visceral leishmaniasis in Somalia: A review of epidemiology and access to care
por: Sunyoto, Temmy, et al.
Publicado: (2017)

Post Kala-Azar Dermal Leishmaniasis following Treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) for Primary Visceral Leishmaniasis in Bihar, India
por: Burza, Sakib, et al.
Publicado: (2014)

Visceral Leishmaniasis-HIV Coinfection as a Predictor of Increased Leishmania Transmission at the Village Level in Bihar, India
por: Cloots, Kristien, et al.
Publicado: (2021)

Risk Factors for Visceral Leishmaniasis Relapse in Immunocompetent Patients following Treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) in Bihar, India
por: Burza, Sakib, et al.
Publicado: (2014)

Five-Year Field Results and Long-Term Effectiveness of 20 mg/kg Liposomal Amphotericin B (Ambisome) for Visceral Leishmaniasis in Bihar, India
por: Burza, Sakib, et al.
Publicado: (2014)

Tuberculosis in Visceral Leishmaniasis-Human Immunodeficiency Virus Coinfection: An Evidence Gap in Improving Patient Outcomes?
por: van Griensven, Johan, et al.
Publicado: (2018)

Rapid tests for the diagnosis of visceral leishmaniasis in patients with suspected disease
por: Boelaert, Marleen, et al.
Publicado: (2014)

Why miltefosine—a life-saving drug for leishmaniasis—is unavailable to people who need it the most
por: Sunyoto, Temmy, et al.
Publicado: (2018)

Visceral Leishmaniasis and HIV Coinfection in East Africa
por: Diro, Ermias, et al.
Publicado: (2014)

Field safety and effectiveness of new visceral leishmaniasis treatment regimens within public health facilities in Bihar, India
por: Goyal, Vishal, et al.
Publicado: (2018)

Uncharted territory of the epidemiological burden of cutaneous leishmaniasis in sub-Saharan Africa—A systematic review
por: Sunyoto, Temmy, et al.
Publicado: (2018)

Evaluation of qPCR on blood and skin microbiopsies, peripheral blood buffy coat smear, and urine antigen ELISA for diagnosis and test of cure for visceral leishmaniasis in HIV-coinfected patients in India: a prospective cohort study
por: Owen, Sophie I, et al.
Publicado: (2021)

Field effectiveness of new visceral leishmaniasis regimens after 1 year following treatment within public health facilities in Bihar, India
por: Goyal, Vishal, et al.
Publicado: (2019)

Visceral Leishmaniasis, Northern Somalia, 2013–2019
por: Aalto, Mikko K., et al.
Publicado: (2020)

AmBisome Monotherapy and Combination AmBisome–Miltefosine Therapy for the Treatment of Visceral Leishmaniasis in Patients Coinfected With Human Immunodeficiency Virus in India: A Randomized Open-Label, Parallel-Arm, Phase 3 Trial( )
por: Burza, Sakib, et al.
Publicado: (2022)

Immunomodulatory Therapy of Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected Patients
por: Adriaensen, Wim, et al.
Publicado: (2018)

“Kala-Azar is a Dishonest Disease”: Community Perspectives on Access Barriers to Visceral Leishmaniasis (Kala-Azar) Diagnosis and Care in Southern Gadarif, Sudan
por: Sunyoto, Temmy, et al.
Publicado: (2018)

Community-based management of severe acute malnutrition in India: new evidence from Bihar(1)(2)(3)
por: Burza, Sakib, et al.
Publicado: (2015)

Eliminating visceral leishmaniasis in South Asia: the road ahead
por: Rijal, Suman, et al.
Publicado: (2019)

Male predominance in reported Visceral Leishmaniasis cases: Nature or nurture? A comparison of population-based with health facility-reported data
por: Cloots, Kristien, et al.
Publicado: (2020)

Prevalence and determinants of asymptomatic Leishmania infection in HIV-infected individuals living within visceral leishmaniasis endemic areas of Bihar, India
por: Mahajan, Raman, et al.
Publicado: (2022)

Exploring global and country-level barriers to an effective supply of leishmaniasis medicines and diagnostics in eastern Africa: a qualitative study
por: Sunyoto, Temmy, et al.
Publicado: (2019)

Visceral Leishmaniasis and HIV Coinfection in the Mediterranean Region
por: Monge-Maillo, Begoña, et al.
Publicado: (2014)

Visceral Leishmaniasis and HIV Coinfection in Latin America
por: Lindoso, José Angelo, et al.
Publicado: (2014)

Visceral leishmaniasis and HIV coinfection: current perspectives
por: Lindoso, José Angelo Lauletta, et al.
Publicado: (2018)

Is Visceral Leishmaniasis the same in HIV-coinfected adults?
por: Henn, Guilherme Alves de Lima, et al.
Publicado: (2018)

Control of Visceral Leishmaniasis in Latin America—A Systematic Review
por: Romero, Gustavo A. S., et al.
Publicado: (2010)

Tegumentary leishmaniasis and coinfections other than HIV
por: Martínez, Dalila Y., et al.
Publicado: (2018)

Long-term Clinical Outcomes in Visceral Leishmaniasis/Human Immunodeficiency Virus–Coinfected Patients During and After Pentamidine Secondary Prophylaxis in Ethiopia: A Single-Arm Clinical Trial
por: Diro, Ermias, et al.
Publicado: (2018)

Visceral Leishmaniasis and HIV Coinfection: Time for Concerted Action
por: van Griensven, Johan, et al.
Publicado: (2014)

Visceral Leishmaniasis Associated with HIV Coinfection in Pará, Brazil
por: Camargo Júnior, Raimundo Nonato Colares, et al.
Publicado: (2023)

“It’s just a fever”: Gender based barriers to care-seeking for visceral leishmaniasis in highly endemic districts of India: A qualitative study
por: Jayakumar, Beulah, et al.
Publicado: (2019)

Epidemiology of Visceral Leishmaniasis in Algeria: An Update
por: Adel, Amel, et al.
Publicado: (2014)

Case Report: Visceral Leishmaniasis with Salmonella Paratyphi and Brucella melitensis Coinfection as a Cause of Persistent Fever in a Patient from Sudan
por: El Safi, Sayda, et al.
Publicado: (2018)

Visceral Leishmaniasis in Rural Bihar, India
por: Hasker, Epco, et al.
Publicado: (2012)

The Household Costs of Visceral Leishmaniasis Care in South-eastern Nepal
por: Uranw, Surendra, et al.
Publicado: (2013)

Xenodiagnosis to address key questions in visceral leishmaniasis control and elimination
por: Singh, Om Prakash, et al.
Publicado: (2020)

Visceral leishmaniasis and COVID-19 coinfection – A case report
por: Pikoulas, Antonis, et al.
Publicado: (2021)

Severe visceral leishmaniasis and COVID-19 coinfection in an immunosuppressed patient
por: Martins, Luciamáre Perinetti Alves, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g504542nuvu2les7fu10kdhm9c